Arcadia Biosciences Cash from Financing (TTM) Insights

Arcadia Biosciences Inc (RKDA)

2.06 -0.02 (-0.75%) USD | NASDAQ | May 10, 16:00

2.06 0.00 (0.00%) After-Hours: 19:42

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	5.512M
September 30, 2023	5.512M
June 30, 2023	10.02M
March 31, 2023	10.02M
December 31, 2022	4.519M
September 30, 2022	4.405M
June 30, 2022	-0.089M
March 31, 2022	-0.093M
December 31, 2021	21.90M
September 30, 2021	29.75M
June 30, 2021	32.04M
March 31, 2021	41.86M
December 31, 2020	20.56M
September 30, 2020	12.80M
June 30, 2020	25.64M
March 31, 2020	22.70M
December 31, 2019	21.99M
September 30, 2019	22.01M
June 30, 2019	6.817M

Date	Value
March 31, 2019	12.43M
December 31, 2018	22.48M
September 30, 2018	22.48M
June 30, 2018	-3.59M
March 31, 2018	-16.08M
December 31, 2017	-26.10M
September 30, 2017	-26.09M
June 30, 2017	0.185M
March 31, 2017	0.318M
December 31, 2016	0.396M
September 30, 2016	0.325M
June 30, 2016	-0.939M
March 31, 2016	71.65M
December 31, 2015	68.87M
September 30, 2015	67.10M
June 30, 2015	67.94M
March 31, 2015	26.92M
December 31, 2014	30.11M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.093M

Minimum

Mar 2022

41.86M

Maximum

Mar 2021

15.68M

Average

12.80M

Median

Sep 2020

Cash from Financing (TTM) Benchmarks